Flemington, NJ, United States of America

Joseph Szanto

This inventor holds 1 USPTO granted patent. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph Szanto. Retrieved from https://idiyas.com/inventor/joseph-szanto-j9vksqo2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joseph Szanto: Innovator in Antibiotic Development

Introduction

Joseph Szanto is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of antibiotics, particularly in the development of taeniacidal agents. His work has implications for both medical research and treatment options.

Latest Patents

Joseph Szanto holds a patent for "Antibiotics LL-AC541 and racemomycin A as taeniacidal agents." This patent highlights the utility of both LL-AC541 and racemomycin A, which are members of the streptothricin family, as effective agents against taenia infections. His innovative approach in this area showcases the potential for new treatments in combating parasitic infections.

Career Highlights

Joseph Szanto is associated with E.R. Squibb & Sons, Inc., where he has contributed to various research initiatives. His work in antibiotic development has positioned him as a key figure in the pharmaceutical industry. With a focus on improving health outcomes, his research continues to influence the field.

Collaborations

Joseph has collaborated with notable colleagues, including William E. Brown and Edward Meyers. These partnerships have fostered a collaborative environment that enhances the research and development of new medical solutions.

Conclusion

Joseph Szanto's contributions to antibiotic research, particularly through his patent on taeniacidal agents, underscore his role as an innovator in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…